KAREN DEAL: Open Payments
NPI 1093856767 · STATESBORO, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$254 in 14 payments from 10 companies in 2025. Trend: 2023 $49 · 2024 $55 · 2025 $254
Food & beverage: $254
| Company | Payments | Amount |
|---|---|---|
| Dexcom, Inc. | 3 | $50 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $33 |
| Boston Scientific Corporation | 1 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $18 |
| Abbott Laboratories | 1 | $16 |
| Exact Sciences Corporation | 1 | $14 |
Products named: Dexcom G6 Transmitter, AIRSUPRA, XIFAXAN, General - Pain Management, REXULTI, MOUNJARO, VRAYLAR, Kerendia.
Industry payments across GA — which companies pay providers there.
